GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has conclu ...
Like so many issues in life, taking a short walk or spin on your bike, can provide some relief when it comes to food noise.
11h
Irish Examiner on MSNOn the rebound: What are the long-term risks of Ozempic?Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) – $8 million – ...
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
Today we'll look at six European stocks that could continue outperforming in 2025. Some of these companies are available to ...
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
When Trova Wine and Market in Dallas shut its doors last month after nearly five years in business, owner Michelle Bonds ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results